Treatment of ovarian cancer with a tropism modified oncolytic adenovirus

Cancer Research

Volumn 62, Issue 5, 2002, Pages 1266-1270

  Bauerschmitz, Gerd J ^a   Lam, John T ^a   Kanerva, Anna ^a   Suzuki, Kaori ^a   Nettelbeck, Dirk M ^a   Dmitriev, Igor ^a   Krasnykh, Victor ^a,c   Mikheeva, Galina V ^c   Barnes, Mack N ^b   Alvarez, Ronald D ^a,b   Dall, Peter ^d   Alemany, Ramon ^e   Curiel, David T ^a   Hemminki, Akseli ^a  

^a Division of Human Gene Therapy   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c VectorLogics Inc   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIVISION; CELL KILLING; CONTROLLED STUDY; GENE THERAPY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOVIRIDAE; ANIMALS; FEMALE; GENE THERAPY; MICE; MICE, SCID; OLIGOPEPTIDES; OVARIAN NEOPLASMS; SPHEROIDS, CELLULAR; VIRUS REPLICATION;

EID: 0036494383     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas
2. Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors
3. Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule
4. Selectivity of TAG-72 targeted adenovirus gene transfer to primary ovarian carcinoma cells versus autologous mesothelial cells in vitro
5. Adenoviruses in oncology: A viable option?
6. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
7. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency
8. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
9. An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
10. Cancer cell cycles
11. 15INK4B) in human ovarian carcinoma cell lines
12. CDKN2A gene inactivation in epithelial sporadic ovarian cancer
13. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression
14. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites
15. Spheroids as a three dimensional model for analysis of replicative viral agents on primary tumor cells
16. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status
17. Clinical research results with d11520 (Onyx-015), a replication selective adenovirus for the treatment of cancer: What have we learned?
18. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
19. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
20. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector